Peptide stacks / KLOW

KLOW

A four-ingredient blend discussed for recovery and skin support.

The short version

Ingredients

Why people discuss it
A community blend discussed for recovery, skin support and inflammation, including gut-focused interest attributed to KPV. Component research does not establish the blend’s benefit or synergy.
What it is
Here, KLOW means BPC-157, TB-500, GHK-Cu and KPV. The name does not guarantee ingredient ratios, exact TB-500 identity, purity or formulation.
Biggest caution
The selected evidence does not establish combination safety. Each ingredient has its own uncertainty, and adding them together does not remove it.
Stack context
Already a four-component combination. No beneficial add-on is established by the selected evidence.

Dose and frequency reference

Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.

Sources report different amounts or schedules; the reference below is a named example, not a consensus.

KLOW 5:1:1:1 blend — subcutaneous

Community reference · Not clinical guidance
Amount
Initial example: 1.25 mg GHK-Cu + 250 mcg each BPC-157, TB-500 and KPV
Frequency
Once daily
Duration / phase
12-week source example; amount changes by phase

Exact-ratio, single-publisher schedule: weeks 1–2 use 2 mg total/day; weeks 3–4 use 4 mg; weeks 5–8 use 6 mg; weeks 9–12 use 4 mg. At the 6 mg peak, GHK-Cu is 3.75 mg and each other ingredient is 750 mcg—above several standalone reference amounts. Components cannot be adjusted independently. This is not a validated KLOW regimen. Reference only; this does not establish safety, effectiveness or individual suitability.

Community source · reviewed 2026-09-27
Compare reported schedules

Saved source material reviewed 2026-09-27. Multiple pages from one publisher count as one source family; agreement does not establish what most people use. SC means subcutaneous; IM intramuscular; IP intraperitoneal.

Evidence & sources · Component evidence only

Community references document claims and reported practices. They are not clinical evidence. Some references contain supplier promotions or market treatment; their commercial context is identified in the source label.

Browse all stacksBack to the peptide library